Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector

Harris Soifer, Collin Higo, Haig H. Kazazian, John V. Moran, Kohnosuke Mitani, Noriyuki Kasahara

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage.

Original languageEnglish (US)
Pages (from-to)1417-1428
Number of pages12
JournalHuman gene therapy
Issue number11
StatePublished - Jul 20 2001
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics


Dive into the research topics of 'Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector'. Together they form a unique fingerprint.

Cite this